Literature DB >> 29505666

E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy.

Juan Pablo Costabel1, Enrique Galve2, María Terricabras2, Clara Ametrano1, Ricardo Ronderos1, Adrian Baranchuk3, Arturo Evangelista2, Gustavo Avegliano1.   

Abstract

INTRODUCTION: Atrial fibrillation (AF) occurs in about 20%-25% of patients with hypertrophic cardiomyopathy and is associated with increased risk of cardioembolism and heart failure impacting on patients' morbidity and mortality. The aim of this study was to identify echocardiographic predictors of AF in a cohort of patients with hypertrophic cardiomyopathy (HCM).
METHODS: Patients were recruited from 2 centers: Buenos Aires Cardiovascular Institute and the Hospital Vall d'Hebron of Barcelona which were analyzed together. Retrospective study using electronic charts.
RESULTS: A total of 321 patients with HCM and no documented history of AF were included. Median follow-up was 3 years. Mean age was 54 ± 16 years. Obstructive HCM was present in 41% of the patients, and 94.2% had preserved systolic function. Thirty-eight patients developed AF during the follow-up period (11.8%). Univariate analysis showed that age, maximum myocardial thickness, atrial area, an E/e' ratio ≥ 17, and systolic pulmonary pressure estimated by echocardiography were associated with new-onset AF. Multivariate analysis showed that E/e' ≥ 17 ratio {HR 3.27 ([1.10-9.27] P = .033)} and atrial area {HR 1.06 ([1.01-1.13] P = .037)} remained predictors of AF.
CONCLUSIONS: An E/e' ratio ≥ 17, as an expression of left ventricular filling pressures with impact on the left atrium, and left atrial area ≥28 cm2 are strong predictors of AF in patients with HCM.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; hypertrophic cardiomyopathy

Mesh:

Year:  2018        PMID: 29505666     DOI: 10.1111/echo.13857

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  4 in total

Review 1.  Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions.

Authors:  Syona S Shetty; Andrew Krumerman
Journal:  Cardiovasc Diabetol       Date:  2022-06-28       Impact factor: 8.949

2.  Strain Analysis of Left Ventricular Function in the Association of Hypertrophic Cardiomyopathy and Systemic Arterial Hypertension.

Authors:  Thereza Cristina Pereira Gil; Marcia Bueno Castier; Alyne Freitas Pereira Gondar; Ana Ferreira Sales; Marceli de Oliveira Santos; Fernanda Cristina da Silva de Lima; Ricardo Mourilhe-Rocha
Journal:  Arq Bras Cardiol       Date:  2019-09-02       Impact factor: 2.000

3.  Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy.

Authors:  Adam Gębka; Renata Rajtar-Salwa; Artur Dziewierz; Paweł Petkow-Dimitrow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-02-09       Impact factor: 1.426

Review 4.  The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review.

Authors:  Jay M Edelberg; Amy J Sehnert; Matthew E Mealiffe; Carlos L Del Rio; Robert McDowell
Journal:  Am J Cardiovasc Drugs       Date:  2022-04-18       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.